Conversion of a Viral Glycan Shield into a Binding Anchor via Causal-Driven Antibody Optimization
Dose optimisation of favipiravir against RNA viruses using physiologically-based pharmacokinetic modelling.
Coevolving Mutations in Chronic SARS-CoV-2 Infections
Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology Approach
DextraDemixer enables accurate identification of antigen-specific T cells from pMHC multimer experiments
Quantitative modeling of SARS-CoV-2 replication reveals phase-specific bottlenecks and antiviral targets
Expanded protocadherin-1 usage reveals a broader hantavirus entry landscape
Adjuvant selection for optimally balanced humoral and cellular immunity induced by SARS-CoV-2 Spike virosome vaccines
Scalable Production of a De Novo SARS-CoV-2 Antiviral miniprotein in Escherichia coli
Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis
Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis
Breath Tests in Infection Control: The Hype and the Hurdles
She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help
Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
Reporters Talk Through FDA Sunscreen Move and Closure of Rural Dialysis Clinics
Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe
Workers with long COVID more likely to leave jobs, lose productivity
Welcome! Everything is fine…except there is still no ACIP quorum: The State of US Vaccine Policy